PCM
CDNA icon

Peregrine Capital Management’s CareDx CDNA Stock Holding History

Peregrine Capital Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-633,282
Closed -$13.7M – 308
2019
Q4 		$13.7M Buy
633,282
+36,943
+6% +$848K 0.35% 124
2019
Q3 		$13.5M Buy
596,339
+154,167
+35% +$4.27M 0.37% 120
2019
Q2 		$15.9M Sell
442,172
-49,524
-10% -$1.59M 0.39% 111
2019
Q1 		$15.5M Sell
491,696
-71,184
-13% -$2.07M 0.39% 116
2018
Q4 		$14.2M Sell
562,880
-29,201
-5% -$750K 0.4% 110
2018
Q3 		$17.1M Buy
+592,081
New +$11.1M 0.4% 114

Other funds holding CDNA

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Peregrine Capital Management's CDNA Position: Q1 2020 in Review

Peregrine Capital Management sold out of CareDx (CDNA) in Q1 2020, closing a stake of 633,282 shares — an estimated $13.7M sold.

Peregrine Capital Management first reported a position in CDNA in Q3 2018 and held it in 6 quarters. The position peaked at $17.1M in Q3 2018. 144 funds tracked by Wall St. Rank hold CDNA as of Q1 2020.

  • Peregrine Capital Management reported no remaining CareDx position as of Q1 2020 after selling out during the quarter.
  • Peregrine Capital Management sold 633,282 CareDx shares in Q1 2020, an estimated $13.7M.
  • Peregrine Capital Management first reported a position in CareDx in Q3 2018 and held it in 6 quarters.
  • Peregrine Capital Management's CareDx position peaked at $17.1M in Q3 2018.
  • 144 funds tracked by Wall St. Rank held CareDx as of Q1 2020.

Based on Peregrine Capital Management's 13F filing for Q1 2020, filed 17 Apr 2020.